A recently introduced automated immunoassay which is based on kinetic interaction of microparticles in solution (Roche ONLINE), was evaluated for the detection of cocaine metabolite benzoylecgonine (BE) and opiates in human urine. Cross-reactivity for the opiates morphine (100%), codeine (88%), 6monoacetylmorphine (88%), and morphine 3-g1ucuronide (72%) was assessed. Analytical recovery evaluated on blank urines spiked with 0, 250, 300, 350, and 500 Jlg/L of morphine and BE (n = 10), varied from 85·2 to 100·2% for opiates and from 81·4 to 93·1 % for the cocaine metabolite. The within-day precision ranged from 1-4 to 4·7% for morphine and from 4·2 to 4·8% for BE. The repeatability of the standards over 1 month was 1·0-3·3% for opiates and 1,7-5,1 % for BE, and thus allowing measurements to continue over 30 days without re-calibration, This method compared favourably with the SYVA EMIT d.a.u™ system and gas chromatography/mass spectroscopy (GC/MS) methods.
Immunoassay is established as the first test in the routine investigation of biological specimens for drugs of abuse, according to national and international guidelines.l ? In order to achieve legal defensibility, all positive results have to be confirmed using chromatographic methods especially chromatography linked to mass spectrometry.' 5 Most of the immunoassays available, such as radioimmunoassay (RIA), enzyme immunoassay (EIA), and fluorescence polarization immunoassay (FPIA) are difficult to automate for large scale application. For example, RIA can be semi-automated, but radioactive waste disposal remains an issue. EIAs and FPIAs usually require some reagent preparation steps, frequent recalibrations and/or dedicated instrumentation. Furthermore, endogenous and exogenous factors Dr can affect the reliability of immunological assays. Chromatographic methods, on the other hand, have 'internal markers', such as retention times, signal-to-noise and ion ratios, to monitor the reliability.
A new homogeneous immunoassay based on measurement of agglutination inhibition, or kinetic interaction of microparticles in solution (named KIMSTM by the manufacturer) is now available to measure drug concentrations. This new technology, reportedly, has high precision, longer stability of calibration (saving time and reagent costs), no reagent preparation steps, better accuracy, and analytical 'ruggedness' in terms of resilience to adulteration.
In this study, we have assessed the performance of the recently developed commercial kits (Roche ONLINE) using the KIMS technology for the analysis of opiates and cocaine metabolite in urine in comparison with the most widely used EIA analysis and specific chromatographic methods.
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MATERIALS AND METHODS
Immunoassays
Reagents for opiates and cocaine metabolite for ONLINE were obtained from Roche Diagnostic Systems (Nutley, NJ, USA) and those for EMIT from SYVA Company (Palo Alto, CA, USA). All assays were performed according to the manufacturers' instructions, using the automated analysers Cobas Mira (Roche) and Solaris (Syva) for ONLINE and EMIT, respectively. Calibrators were obtained from the reagent manufacturer. Concentration of calibrators for 'ONLINE' assay were 0, 150, 300, and 600 J.lg/L and for EMIT assay they were 0, 300, and 1000 J.lg/L for opiates and 0, 300, and 3000 J.lg/L for cocaine. Accuracy was assessed by comparing the observed values with the 'true' values established by reference methods or by recovery studies using spiked samples.
Sample preparation prior to chromatography To 2'5mL of urine a lO0J.lg of nalorphine solution (80 mg/L) was added as internal standard (IS). The pH was then adjusted to nine with borate buffer, the volume made up to 10mL vortex mixed for 10min and poured into a Chemelut extraction column (Yarian, Harbor City, CA, USA). After 10min, elution was carried out with 20mL of 10% isopropyl alcohol in dichloromethane. The eluate was evaporated under a stream of nitrogen and the residue was reconstituted with O' 3 mL of methanol for analysis by G'C, The hydrolysis of urines was accomplished by addition of 5 mL of acetate buffer (sodium acetate I mol/L adjusted to pH 5·5 with acetic acid) and 50 J.lL of pglucuronidase (Helix pomatia, activity 100000 units/ml.; Sigma, St Louis, Missouri, USA) to the sample containing the IS in a 10mL screw capped tube. The mixture was vortex mixed and incubated at 55°C for 1h. After cooling, 50 J.lL of 2·5mol/L sodium hydroxide and 4mL of saturated borate solution (pH 9) were added and extracted as described above.
Chromatographic, chromatographic/ mass spectrometric methods A Hewlett-Packard (Avondale, PA, USA) Model 5890 gas chromatograph with a HP7673A autosampler and NPD detector (also from Hewlett-Packard), fitted with a cross-linked methylsilicone coated fused silica capillary column (25 m x 0·22 mm ID, film thickness 0·11 J.lm) was used. A well established GC procedure" was adopted for the analysis of Ann Clin Biochem 1997: 34 cocaine, benzoylecgonine (BE), morphine, codeine, and 6-monoacetylmorphine. Gas chromatography/mass spectrometry (GC/MS) was carried out with a similar chromatographic instrument, fitted with a HP5791 mass selective detector controlled by a MS Chern Station (both from Hewlett-Packard); ionization energy was 70 eY, and detector temperature was 190°C. Derivatization was carried out using a previously described procedure." The extracts were evaporated to dryness under nitrogen and 100 J.lL of pentafluoropropionic anhydride (PFPA) along with 50 J.lL of hexafluoroisopropanol (HFIP) were added. The vials were sealed and incubated for 30 min at 60°C and then carefully evaporated to dryness under nitrogen. The dried extracts were redissolved with 100J.lL of ethyl acetate and injected into the analytical system. The system was operated in selective ion monitoring mode (SIM). The selected ions for the different analytes of interest were: 182, 345, 314 for ecgonine methyl ester-PFP; 182,303,272 for cocaine; 318, 439, 334 for BE-HFIP; 414, 577,430 for morphine-PFP; 414, 473, 361 for 6monoacetylmorphine-PFP; 282, 445, 388 for codeine PFP and 440, 456, 357 for nalorphine-PFP.
RESULTS AND DISCUSSION
For the GC method, the average analytical recoveries were 90% for morphine (CY = 3·8%, n = 8), 93% for codeine (CY = 4'0%, n = 8), 80% for 6-monoacetylmorphine (CY = 5·0%, n = 8), and 98% for cocaine (CY = 7·0%, n = 8). The quantitative determination of the above mentioned analytes was linear up to 10mg/L, The limits of detection (signal-to-noise ratio > 2) were 20 J.lg/L for all the analytes except for morphine, for which it was 40 J.lg/L. When morphine and BE concentrations were less than the detection limits of other methods GCfMS in SIM mode was adopted, with nalorphine as IS, using the peak area ratios of ions 414:440 for morphine and 318:440 for BE. The calibration curves were linear over the range 0'1-2, 5 mg/L, The limit of detection was 10 J.lg/L for both analytes. The precision of the method determined using quality control samples were 5% and 3% (n = 8) for morphine and BE, respectively, at a concentration of 0·1 mg/L, The recovery for morphine and BE was 85% and 72%, respectively. Ecgonine methyl ester was always investigated, but not routinely quantitated.
TABLE I. Within-day precision and recovery: urines fortified to contain known concentrations of morphine and benzoy/ecgonine, assayed 10 times
KIMS imrnunometric technology (ONLINE)
The day-to-day repeatability of the curves over 1 month (n = 19) was excellent. In terms of changes in absorbance, the CV's at 0, 150, 300, and 600J.Lg/L were 1·7, 4·6, 5,1, and 4·3%, respectively. The recalculated concentrations (and respective CVs) of the calibration standards were 0·5 (33'3%), 137·0 (22'6%), 275·7 (12-4%), and 524·8 J.Lg/L (12'3%), respectively.
The CVs for the opiate calibrators were 1·3, 3·3,2·3, and 1'9%, respectively, at 0, 150,300, and 600 J.Lg/L. The overall performance of ON-LINE in this stability test was within acceptable analytical parameters for tests of its type, even though reagent solutions were not changed.
ONLINE within-day precision and accuracy was carried out by repeated assays (n = 10) of a control urine (Urine Toxicology Control Low, Bio-Rad ECS Division, Milan, Italy), containing 493 J.Lg/L of total morphine (255 J.Lg/L glucuronated and 238 J.Lg/L free morphine) and 458 J.Lg/L of BE, as confirmed by GC analysis. The average results with ONLINE were 531 J.Lg/L for opiates (7% above the target; CV 2,0%) and 469 J.Lg/L for the cocaine metabolite (2% above the target; CV 3,4%). ONLINE within-day performance (n = 10) was also tested around Automated immunoassay for drugs of abuse 83 the traditional cut-off concentration of 300 J.Lg/L on urine samples spiked to contain 250, 300, 350, and 500 J.Lg/L of morphine and BE. Experimental recoveries varied from 85 to 100% for opiates and from 81 to 93% for the cocaine metabolite [(CVs ranging from 1-4 to 4·7% and from 4·2 to 4·8%, respectively) (Table I) ]. The inter-assay (n = 5) recovery measured on urine samples spiked to contain 350 J.Lg/L of morphine and BE was 88% (CV = 3,8%) for the opiate assay and 87 (CV = 8'2%) for the cocaine metabolite.
The cross-reactivity of the ONLINE opiate antiserum for codeine, 6-monoacetylmorphine, and morphine 3-glucuronide at 300 J.Lg/L was 88%, 72% and 88%, respectively.
When 35 urines which were negative for opiates and cocaine metabolites by the EMIT method were tested with the new immunoassay, all the samples were below 300 J.Lg/L. However, seven urines showed significant absorbances (more than 2 SD higher than the 0 control). These samples were tested by GC/MS and results were available for five out of seven samples. The results summarized in Table 2 show that ONLINE method has the potential to reliably detect concentrations of analytes lower than the established cut-ofTs.
Samples from 24 drug users in which opiates were detected by GC/NPD or GC/MS were analysed by the ONLINE method. All samples were found to contain opiates (concentration range 0-43 to 194·0 mg/L), In order to meet the high throughput requirements of high volume routine testing of drugs of abuse simple and fully automated (commercial) methods are required. Immunometric methods, based on complex interactions of biomolecules (including not only immuno-affinity, but also enzymatic activity and steric inhibition, as in EIAs) take place in untreated biological matrices of relatively non-standard composition, such as Smith et at.
CONCLUSIONS
urine. In this regard, the simpler KIMS technology, used in ONLINE, appears to be more robust than EIA towards interferences from common adulterants (sodium chloride, acetic acid, bicarbonate), which can be intentionally added to the urine specimen to vitiate the tests." The results of this study corroborate recent reportst" and suggests that KIMS technology may have advantages for testing drugs of abuse.
